LU Jinying, CHANG Taotao, ZHANG Jingjing, LIU Lijuan, YAN Ping, YIN Zhanru. Analysis of clinical value of serum inflammatory factors combined with pulmonary function index in identification of severe mycoplasma pneumonia in children[J]. Journal of Clinical Medicine in Practice, 2024, 28(6): 65-68, 73. DOI: 10.7619/jcmp.20233960
Citation: LU Jinying, CHANG Taotao, ZHANG Jingjing, LIU Lijuan, YAN Ping, YIN Zhanru. Analysis of clinical value of serum inflammatory factors combined with pulmonary function index in identification of severe mycoplasma pneumonia in children[J]. Journal of Clinical Medicine in Practice, 2024, 28(6): 65-68, 73. DOI: 10.7619/jcmp.20233960

Analysis of clinical value of serum inflammatory factors combined with pulmonary function index in identification of severe mycoplasma pneumonia in children

More Information
  • Received Date: December 06, 2023
  • Revised Date: February 04, 2024
  • Available Online: April 01, 2024
  • Objective 

    To investigate the clinical value of serum interleukin-6 (IL-6) and interleukin-8 (IL-8) levels in combination with pulmonary function indicators in identifying severe Mycoplasma pneumoniae pneumonia (MPP) in children.

    Methods 

    A total of 102 children with severe MPP were selected as the study subjects (severe group), and another 102 children with mild MPP treated during the same period were selected as the mild group. The serum levels of IL-6, IL-8 as well as forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1 percentage of predicted (FEV1%pred) and the ratio of FEV1 to FVC at the time of admission of children in each group were compared.

    Results 

    The serum levels of IL-6 and IL-8 in the severe group were significantly higher than those in the mild group, while the FVC, FEV1%pred, and FEV1/FVC% were significantly lower than those in the mild group (P < 0.05). The serum levels of IL-6 and IL-8 were negatively correlated with FVC, FEV1%pred and FEV1/FVC% (P < 0.05). The area under the curve (AUC) for assessing the severity of MPP for IL-6, IL-8, FVC, FEV1%pred and FEV1/FVC% was 0.894 (0.849 to 0.939), 0.842 (0.787 to 0.897), 0.896 (0.851 to 0.942), 0.787 (0.725 to 0.849) and 0.744 (0.676 to 0.812), respectively. The AUC for the combined assessment of the above five parameters was 0.985 (0.973 to 0.997).

    Conclusion 

    Serum IL-6, IL-8 and pulmonary function indicators can reflect the severity of MPP in children. Their combined detection can be used to differentiate between mild and severe MPP in children early and timely.

  • [1]
    吴琰, 魏会平, 曹欣, 等. 儿童下呼吸道肺炎支原体感染流行特点分析[J]. 新发传染病电子杂志, 2021, 6(4): 336-338. https://www.cnki.com.cn/Article/CJFDTOTAL-XFCR202104017.htm
    [2]
    徐瑛芳, 朱利华. 儿童下呼吸道肺炎支原体感染流行病学与耐药基因研究进展[J]. 中文科技期刊数据库(引文版)医药卫生, 2021(2): 19-20. https://www.cnki.com.cn/Article/CJFDTOTAL-GYKX202314004.htm
    [3]
    张冰, 陈志敏. 2000-2006年杭州市三岁以上儿童肺炎支原体肺炎临床特征变化趋势[J]. 中华儿科杂志, 2010, 48(7): 531-534.
    [4]
    赵莹, 姚丛月. 血清25-羟维生素D水平与儿童肺炎支原体肺炎心肌损伤的相关性研究[J]. 临床肺科杂志, 2023, 28(7): 1020-1023. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFK202307010.htm
    [5]
    郭旭伟, 张利果, 冯毅. IL-6、PCT及补体水平与肺炎支原体肺炎患儿病情严重程度的相关性及对预后的预测价值[J]. 分子诊断与治疗杂志, 2023, 15(1): 99-102, 106. https://www.cnki.com.cn/Article/CJFDTOTAL-YXYQ202301024.htm
    [6]
    许丽萍, 梁利红, 曹欢, 等. 脾氨肽口服冻干粉联合阿奇霉素对支原体大叶性肺炎患儿血清IL-2、IL-8水平及免疫功能的影响价值分析[J]. 中国医学工程, 2023, 31(3): 101-104. https://www.cnki.com.cn/Article/CJFDTOTAL-YCGC202303020.htm
    [7]
    王慧英, 汤昱, 董利利, 等. 肺泡灌洗技术联合免疫球蛋白对重症支原体肺炎患儿肺功能、免疫功能以及炎症因子水平的影响[J]. 黑龙江医学, 2023, 47(4): 419-422. https://www.cnki.com.cn/Article/CJFDTOTAL-HLYX202304007.htm
    [8]
    中华医学会. 儿童肺炎支原体肺炎诊治专家共识(2015年版)[J]. 中华实用儿科临床杂志, 2015, 30(17): 1304-1308.
    [9]
    中华医学会. 儿童社区获得性肺炎管理指南(2013修订)[J]. 中华儿科杂志, 2013, 51(10): 745-752. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHFY201406007.htm
    [10]
    CHEN Y C, HSU W Y, CHANG T H. Macrolide-resistant Mycoplasma pneumoniae infections in pediatric community-acquired pneumonia[J]. Emerg Infect Dis, 2020, 26(7): 1382-1391.
    [11]
    JIANG Z L, LI S H, ZHU C M, et al. Mycoplasma pneumoniae infections: pathogenesis and vaccine development[J]. Pathogens, 2021, 10(2): 119.
    [12]
    HU J, YE Y Y, CHEN X X, et al. Insight into the pathogenic mechanism of Mycoplasma pneumoniae[J]. Curr Microbiol, 2022, 80(1): 14.
    [13]
    KAUR S, BANSAL Y, KUMAR R, et al. A panoramic review of IL-6: structure, pathophysiological roles and inhibitors[J]. Bioorg Med Chem, 2020, 28(5): 115327.
    [14]
    TANAKA T, NARAZAKI M, MASUDA K, et al. Regulation of IL-6 in immunity and diseases[J]. Adv Exp Med Biol, 2016, 941: 79-88.
    [15]
    LIU J F, ZHANG C X, LI R F, et al. IL-8 is upregulated in the tissue-derived EVs of odontogenic keratocysts[J]. Biomed Res Int, 2022, 2022: 9453270.
    [16]
    NUEANGPHUET P, SUWANRUENGSRI M, FUKE N, et al. Neutrophil and M2-polarized macrophage infiltration, expression of IL-8 and apoptosis in Mycoplasma hyopneumoniae pneumonia in swine[J]. J Comp Pathol, 2021, 189: 31-44.
    [17]
    FAN H F, LU B T, YANG D Y, et al. Distribution and expression of IL-17 and related cytokines in children with Mycoplasma pneumoniae pneumonia[J]. Jpn J Infect Dis, 2019, 72(6): 387-393.
    [18]
    ARAE K, HIRATA M, KURATA S, et al. Mycoplasma pneumoniae induces interleukin-8 production via the epidermal growth factor receptor pathway[J]. Microbiol Immunol, 2011, 55(10): 748-750.
    [19]
    胡奕卿, 方继伟, 刘焕兵. 肺功能检查技术如何在基层医疗卫生服务中更好地应用: 附重点问题专家解答[J]. 中国全科医学, 2023, 26(5): 532-540. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202305003.htm
    [20]
    杨静, 卢旭. 呼出气一氧化氮和肺功能检测在儿童肺炎支原体肺炎中的临床意义[J]. 武警后勤学院学报: 医学版, 2021, 30(12): 104-106. https://www.cnki.com.cn/Article/CJFDTOTAL-WUXB202112040.htm
    [21]
    李静, 郭蕾蕾, 赵学青, 等. 肺功能检测在儿童肺炎支原体肺炎中的应用进展[J]. 中文科技期刊数据库(全文版)医药卫生, 2021(8): 177-179. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGUD202112011.htm
    [22]
    魏然, 臧金萍, 朱婉凌, 等. 支气管哮喘患者气道炎症与肺炎支原体感染的关系研究[J]. 中华医院感染学杂志, 2016, 26(17): 3927-3929. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201617030.htm
  • Cited by

    Periodical cited type(2)

    1. 孔颖颖,邱小建,徐娟玉,王娟. 重症支原体肺炎患儿不同时期行支气管灌洗术的临床特征及影响因素. 中国临床医生杂志. 2025(02): 229-232 .
    2. 罗华. 阿奇霉素联合布地奈德混悬液雾化吸入治疗支原体肺炎患儿的效果分析. 中外医疗. 2024(23): 124-127 .

    Other cited types(0)

Catalog

    Article views (122) PDF downloads (11) Cited by(2)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return